Clinical Trial Update: 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of 4SC-201 (resminostat) for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Resminostat (resminostat)

Snippet

Sponsor: 4SC AG | Conditions: Advanced Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED